GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

HitGen Ink Deal with Cambridge Molecular to Create a Deep Learning-Driven Drug Discovery Platform
2021-11-08
Moderna Enters Gene Editing Market with Metagenomi Collaboration
2021-11-03
AstraZeneca Trims Pipeline By Selling Two Respiratory Drugs to Covis Pharma
2021-11-02
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
Amicus Therapeutics Spins Off Its Gene Therapy Unit in a SPAC Deal
2021-10-02
Sanofi Abandons mRNA-Based COVID-19 Vaccine Plan but Indian Biotechs March On
2021-09-28
Decreasing Earnings and COVID Delays Spell Trouble for AGCT
2021-09-26
Allay Therapeutics Raises $60 Million to Finance its Non-Opioid Pain Management Platform
2021-09-16
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Pfizer Jumps into the CD47 Race With $2.3B Buyout of Trillium
2021-08-24
This CRISPR-Based Test Can Detect COVID-19 Variants From Your Spit
2021-08-13
Kite to Invest in Next Generation Immunotherapy with Appia Bio Collaboration
2021-08-06
After FDA Lifts Hold, Novartis to Proceed with Clinical Trials for Expensive Rare Disease Therapy
2021-08-04
Moderna Banks on Autolus’ Proprietary Tech to Advance Immuno-Oncology Pipeline
2021-08-03
1 2 3 4 9
Scroll to Top